Vasa Denticity Ltd

Vasa Denticity Earnings Call Transcript: Key Takeaways

Revenue up 19.4% to ₹87.1 Cr; EBITDA ₹7.24 Cr, margin 8.31% vs 8.01%. Margin gain driven by opex cut; gross margin fell ~6 pts amid stock rebuild.

Vasa Denticity Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹87.10 Cr (+19.4% YoY), PAT ₹5.20 Cr (+8.8%), Op. EBITDA ₹7.24 Cr (+23.9%, 8.3% margin). Margin recovery driven by lower operating costs, not gross margin.

Vasa Denticity Management Change

Vasa Denticity re-appointed Independent Director Varun Chugh for five years, effective November 6, 2026. Shareholder approval at a general meeting is pending.

Execution

November 6, 2026 to November 6, 2031

Vasa Denticity Q2 FY27 Results: Net Profit ₹5.2 Cr, Up 8.3% YoY

Vasa Denticity Ltd reported revenue from operations of ₹87.1 Cr (+19.5% YoY) and net profit of ₹5.2 Cr (+8.3% YoY) for Q2 FY27.

Key figure

Net profit ₹5.2 Cr · +8.3% YoY

Vasa Denticity Board Meeting Date

VASA Denticity Limited will hold a board meeting on 06-Nov-2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closure is in effect from 01-Oct-2026.

Vasa Denticity Convertible Warrants

Vasa Denticity received NSE trading approval for 1,50,000 shares from preferential warrant conversion. Listed capital rises to ₹17.49 crore, with trading from 02 November 2026.